Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Analysis-A court battle raises the question - how far will Japan swallow poison pills?

Stock MarketsOct 25, 2021 07:22AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
3/3 © Reuters. A miniature model of Tokyo Kikai Seisakusho Ltd.'s Color Top 5000CD newspaper rotary press is displayed at the company headquarters office in Tokyo, Japan October 21, 2021. REUTERS/Issei Kato 2/3

By Makiko Yamazaki

TOKYO (Reuters) - The fate of future hostile takeover bids in Japan could rest on an upcoming court ruling that will decide whether the country's top maker of newspaper printing presses can move forward with a poison pill against an unwelcome shareholder.

At issue is whether 105-year-old Tokyo Kikai Seisakusho Ltd will be allowed to not count votes from Asia Development Capital (ADC) - an investment firm that built up most of its 40% stake in a matter of weeks - when shareholders vote on issuing new stock that would dilute ADC's ownership.

A holding of more than 33% in Japan gives the stakeholder veto rights over important board decisions and sometimes de facto control.

ADC has sought an injunction and the Tokyo District Court's ruling - the first one to look at an attempt to exclude an investor from a shareholder vote on a poison pill - is expected sometime in the next week. A victory for Tokyo Kikai holds the potential to make it much easier for other Japanese companies to use poison pills.

Tokyo Kikai, which has said ADC hurts its corporate value, will put the poison pill plan to a shareholder vote at an extraordinary general meeting on Friday.

The battle highlights both a rise in hostile takeovers in Japan over the past few years as the practice - once considered the domain of unscrupulous corporate raiders - loses its stigma as well as what some experts see as inadequate Japanese takeover rules that leave companies, small ones especially, too defenceless.

It also comes at a time when investors are watching to see if a drive by Japan's new prime minister, Fumio Kishida, to roll back some of the pro-market policies of former premier Shinzo Abe will impact corporate governance.

Corporate governance experts say it is too difficult to call which way the court might rule.

On one hand, ADC's argument that a ruling in Tokyo Kikai's favour would fly in the face of shareholder equality is a strong one as the principle is enshrined in Japanese corporate law, they say.

"If a target company can select who is allowed to vote on a poison pill, it will come up with all kinds of excuses to create a list of eligible shareholders who have the best chance of passing the pill," said Takumi Watanabe, executive officer at proxy advisory firm QuestHub.

QuestHub said it is not involved in the transaction.

But governance experts add the court might decide that ADC counts as an "abusive buyer" that could threaten the rights of minority shareholders, having rapidly built up its stake and not presented the company or other shareholders with a new management plan.

IT WOULDN'T HAPPEN OVERSEAS

Nearly a decade ago, more than 500 Japanese firms had a permanent poison pill, typically part of their company's articles of incorporation. But the practice - oft criticised for entrenching bad management - fell out of favour after corporate governance reforms pushed by Abe required institutional investors to disclose how they voted on agenda items at shareholder meetings, including poison pills.

(GRAPHIC: Number of firms with anti-takeover measures in Japan - https://graphics.reuters.com/JAPAN-MA/gdpzywbelvw/chart.png)

A poison pill that targets a specific bidder - called an emergency poison pill in Japan - was first successfully employed last year by Toshiba (OTC:TOSYY) Machine, renamed Shibaura Machine, in its fight against prominent activist investor Yoshiaki Murakami.

Since then at least five other firms including Tokyo Kikai have either introduced them or sought to introduce them. Among them, Shinsei Bank plans to seek shareholder approval https://www.reuters.com/business/shinsei-bank-plans-poison-pill-defence-against-sbis-11-bln-bid-sources-2021-09-17 for a poison pill to thwart online financial conglomerate SBI Holdings' $1.1 billion bid.

Experts say the current wave of poison pill activity underscores a lack of clarity over what Japanese companies can do to block takeover bids.

They note Japanese small cap firms are particularly vulnerable to aggressive stake-building from unwelcome stakeholders. Tokyo Kikai, for example, has a market value of just 15 billion yen ($130 million).

Unlike the United States, Japanese company boards cannot swiftly adopt a poison pill to ward off a hostile suitor. Though not explicitly written in law, court precedents have led them to believe they must seek shareholder approval before adopting a poison pill - a time-consuming process.

In Europe, tender offers are usually mandatory for acquisitions of stakes beyond a certain threshold - 30% in the UK - a rule that would prevent cases like Tokyo Kikai's.

Wataru Tanaka, a corporate law professor at the University of Tokyo who submitted a letter of opinion to the court on behalf of Tokyo Kikai, believes the government should prioritise fixing the country's takeover rules.

"Poison pills are a second-best solution," he said.

($1 = 114.3800 yen)

Analysis-A court battle raises the question - how far will Japan swallow poison pills?
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email